First-pass Magnetic Resonance Imaging Research Articles

Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis

Hyperemia is a major criterion for the diagnosis of acute myocarditis on cardiac magnetic resonance imaging but its assessment is challenging and time consuming. We evaluated the usefulness of the contrast-enhanced first-pass perfusion (FPP) on magnetic resonance imaging for detecting subepicardial hyperemia in acute myocarditis. Forty-seven consecutive patients (mean age: 42 ± 15.6years; 35 men) with a definite diagnosis of acute myocarditis according to the state-of-the-art guidelines were included and compared with 16 control subjects. FPP was evaluated by 2 blinded observers and compared with the reference late gadolinium enhancement. Detection of hyperemia was performed on both qualitative and quantitative methods. Relative increased signal intensity (SI) in the subepicardial hyperemic layer was measured with SI ratio (SI of the subepicardial layer/SI of the immediately adjacent subendocardial layer). Twenty-four patients (51%) with acute myocarditis exhibited subepicardial hyperemia, detected with a good interobserver reproducibility (kappa coefficient: 0.75). The SI in the myocardium of myocarditis patients was increased compared with controls (1.08 ± 0.03 vs 0.945 ± 0.04, p= 0.03) and the SI in myocarditis patients with hyperemia compared with those without hyperemia (1.22 ± 0.04 vs 0.94 ± 0.04, p <0.0001). Sensitivity, specificity, positive predictive, and negative predictive values of FPP for detecting hyperemia were 85%, 94%, 85%, and 93%, respectively. In conclusion, contrast-enhanced first-pass magnetic resonance imaging is a fast and useful method for assessing myocardial hyperemia in patients with acute myocarditis.

Assessment of myocardial perfusion with MRI using a modified dual bolus method

Quantification of regional myocardial blood flow (rMBF) with first-pass magnetic resonance imaging (FP-MRI) requires two contrast agent injections (dual bolus technique), inducing error in the determined rMBF if the injections differ. We hypothesize that using input and residue curves of the same injection would be more reliable. We aim to introduce and evaluate a novel method to correct the high concentration arterial input function (AIF) for determination of rMBF. Sixteen patients with non-Hodgkin's lymphoma were examined before and after chemotherapy. The input function was solved by correcting initial high concentration AIF using the ratio of low and high contrast AIF areas, normalized by corresponding heart rates (modified dual bolus method). For comparison, the scaled low contrast AIF was used as an input function (dual bolus method). Unidirectional transfer coefficient Ktrans was calculated using both methods. Ktrans-values determined with the dual bolus (0.81 ± 0.32 ml g−1 min−1) and modified dual bolus (0.77 ± 0.42 ml g−1 min−1) methods were in agreement (p = 0.21). Mean Ktrans-values increased from 0.76 ± 0.43 to 0.89 ± 0.55 ml g−1 min−1 after chemotherapy (p = 0.17). The modified dual bolus technique agrees with the dual bolus technique (R2 = 0.899) when the low and high contrast injections are similar. However, when this is not the case, the modified dual bolus technique may be more reliable.

Contrast Agent Bolus Dispersion in a Realistic Coronary Artery Geometry: Influence of Outlet Boundary Conditions

Myocardial blood flow (MBF) quantification using contrast-enhanced first-pass magnetic resonance imaging relies on the precise knowledge of the arterial input function (AIF). Due to vascular transport processes, however, the shape of the AIF may change from the left ventricle where the AIF is measured to the myocardium. We employed computational fluid dynamics simulations in a realistic model of the left circumflex artery to investigate the degree to which this effect corrupts MBF quantification. Different outlet boundary conditions were applied to examine their influence on the solution. Our results indicate that vascular transport processes in realistic coronary artery geometries give rise to non-negligible systematic errors in the MBF values. The magnitude of these errors differs considerably between the outlets of the 3D model. Moreover, outlet boundary conditions are shown to have a significant influence on the outflows at the outlets of the 3D model. In particular, the employed boundary conditions respond differently to an artificially inserted stenosis and to hyperemia condition. Finally, outlet boundary conditions are shown to have an influence on the resulting MBF value. Since MBF errors are different under rest and under hyperemia conditions, overestimation of myocardial perfusion reserve values may occur as well.

Computational Fluid Dynamics Simulations of Contrast Agent Bolus Dispersion in a Coronary Bifurcation: Impact on MRI-Based Quantification of Myocardial Perfusion

Contrast-enhanced first-pass magnetic resonance imaging (MRI) in combination with a tracer kinetic model, for example, MMID4, can be used to determine myocardial blood flow (MBF) and myocardial perfusion reserve (MPR). Typically, the arterial input function (AIF) required for this methodology is estimated from the left ventricle (LV). Dispersion of the contrast agent bolus might occur between the LV and the myocardial tissue. Negligence of bolus dispersion could cause an error in MBF determination. The aim of this study was to investigate the influence of bolus dispersion in a simplified coronary bifurcation geometry including one healthy and one stenotic branch on the quantification of MBF and MPR. Computational fluid dynamics (CFD) simulations were combined with MMID4. Different inlet boundary conditions describing pulsatile and constant flows for rest and hyperemia and differing outflow conditions have been investigated. In the bifurcation region, the increase of the dispersion was smaller than inside the straight vessels. A systematic underestimation of MBF values up to −16.1% for pulsatile flow and an overestimation of MPR up to 7.5% were found. It was shown that, under the conditions considered in this study, bolus dispersion can significantly influence the results of quantitative myocardial MR-perfusion measurements.

Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: A pilot study

We hypothesized that percutaneous intervention in the affected lower extremity artery would improve calf muscle perfusion and cellular metabolism in patients with claudication and peripheral artery disease (PAD) as measured by magnetic resonance imaging (MRI) and spectroscopy (MRS). Ten patients with symptomatic PAD (mean ± SD: age 57 ± 9 years; ankle-brachial index (ABI) 0.62 ± 0.17; seven males) were studied 2 months before and 10 months after lower extremity percutaneous intervention. Calf muscle phosphocreatine recovery time constant (PCr) in the revascularized leg was measured by (31)P MRS immediately after symptom-limited exercise on a 1.5-T scanner. Calf muscle perfusion was measured using first-pass gadolinium-enhanced MRI at peak exercise. A 6-minute walk and treadmill test were performed. The PCr recovery time constant improved significantly following intervention (91 ± 33 s to 52 ± 34 s, p < 0.003). Rest ABI also improved (0.62 ± 0.17 to 0.93 ± 0.25, p < 0.003). There was no difference in MRI-measured tissue perfusion or exercise parameters, although the study was underpowered for these endpoints. In conclusion, in this pilot study, successful large vessel percutaneous intervention in patients with symptomatic claudication, results in improved ABI and calf muscle phosphocreatine recovery kinetics.

Quantitative myocardial perfusion magnetic resonance imaging: the impact of pulsatile flow on contrast agent bolus dispersion

Myocardial blood flow (MBF) can be quantified using T1-weighted first-pass magnetic resonance imaging (MRI) in combination with a tracer-kinetic model, like MMID4. This procedure requires the knowledge of an arterial input function which is usually estimated from the left ventricle (LV). Dispersion of the contrast agent bolus may occur between the LV and the tissue of interest. The aim of this study was to investigate the dispersion under conditions of physiological pulsatile blood flow, and to simulate its effect on MBF quantification. The dispersion was simulated in coronary arteries using a computational fluid dynamics (CFD) approach. Simulations were accomplished on straight vessels with stenosis of different degrees and shapes. The results show that dispersion is more pronounced under resting conditions than during hyperemia. Stenosis leads to a reduction of dispersion. In consequence, dispersion results in a systematic MBF underestimation between −0.4% and −9.3%. The relative MBF error depends not only on the dispersion but also on the actual MBF itself. Since MBF under rest is more underestimated than under stress, myocardial perfusion reserve is overestimated between 0.1% and 4.5%. Considering other sources of errors in myocardial perfusion MRI, systematic errors of MBF by bolus dispersion are relatively small.

Heterogeneous Microinfarcts Caused by Coronary Microemboli: Evaluation with Multidetector CT and MR Imaging in a Swine Model

To directly compare the sensitivity of 64-section multidetector computed tomography (CT) with that of 1.5-T magnetic resonance (MR) imaging in the depiction and measurement of heterogeneous 7-8-week-old microinfarcts and the quantification of regional left ventricular (LV) function and perfusion in the territory of coronary intervention in a swine model. Approval was obtained from the institutional animal committee. An x-ray/MR system was used to catheterize the left anterior descending (LAD) coronary artery with x-ray guidance and to delineate the perfusion territory. The vessel was selectively microembolized in six pigs with small-diameter embolic material (40-120 microm, 250000 count). At 7-8 weeks after microembolization, multidetector CT and MR imaging were used to assess LV function, first-pass perfusion, and delayed contrast enhancement in remote myocardium and microinfarct scars. Histochemical staining with triphenyltetrazolium chloride (TTC) was used to confirm and quantify heterogeneous microinfarct scars. The two-tailed Wilcoxon signed rank test was used to detect differences between modalities and myocardial regions. The LAD territory was 32.4% +/- 3.8(stadard error of the mean) of the LV mass. Multidetector CT and MR imaging have similar sensitivity in the detection of regional and global LV dysfunction and extent of microinfarct. The mean LV end-diastolic volume, end-systolic volume, and ejection fraction were 93 mL +/- 8, 46 mL +/- 4, and 50% +/- 3, respectively, on multidetector CT images and 92 mL +/- 8, 48 mL +/- 5, and 48% +/- 3, respectively, on MR images (P > or = .05). The extent of heterogeneous microinfarct was not significantly different between multidetector CT (6.3% +/- 0.8 of the LV mass), MR imaging (6.6% +/- 0.5 of the LV mass), and TTC staining (7.0% +/- 0.6 of the LV mass). First-pass multidetector CT and MR imaging demonstrated significant regional differences (P < .05) in time to peak between the heterogeneous microinfarct and remote myocardium (17.0 seconds +/- 0.3 and 12.4 seconds +/- 0.6, respectively, for multidetector CT and 17.2 seconds +/- 0.8 and 12.5 seconds +/- 1.0, respectively, for MR imaging). Modern multidetector CT and MR imaging are sensitive modalities with which to depict heterogeneous microinfarcts and determine regional LV dysfunction and decreased perfusion in the territory of intervention. (c) RSNA, 2010.

Abstract 5087: LDL Lowering Does Not Improve Calf Muscle Perfusion or Energetics or Exercise Performance in Peripheral Arterial Disease

Introduction. Prior studies suggest benefit of statins on walking performance in patients with peripheral arterial disease (PAD). Hypothesis. We hypothesized that LDL reduction in PAD would improve calf muscle perfusion and energetics as assessed by magnetic resonance imaging (MRI) and spectroscopy (MRS). Methods. Fifty eight patients with mild-to-moderate symptomatic PAD (mean±SD age 63±10 years, ankle brachial index (ABI) 0.70±0.14) were studied before and 1 year after therapy with simvastatin 40mg or simvastatin 40mg/ezetimibe 10mg (R,n=31) if statin-naive or ezetimbibe 10mg (Z,n=27) if on a statin. Calf muscle phosphocreatine recovery time constant (PCr) was measured using 31 phosphorus MRS immediately after symptom-limited exercise on a 1.5T scanner. Calf muscle perfusion was measured using first-pass contrast-enhanced MRI with 0.1 mM/kg gadolinium infused at peak exercise, (n=44 after excluding those with renal dysfunction). Time intensity curves in calf muscle were normalized to nearby proton density and the upslope was used to assess perfusion. Gadolinium-enhanced MRA was graded for number and degree of stenoses. Patients performed a 6 minute walk and Skinner-Gardner treadmill test with VO 2 measurement. Changes in parameters between groups were analyzed with F-test and between time point with paired t-test. Results. LDL at baseline was higher in R than Z (118±36 verus 103±25 mg/dl), p=0.07 and decreased more in R than Z (−42±35 versus −21±32), p=0.02 resulting in similar final LDL. There were no differences in any of the MRI or exercise parameters between treatment groups. See table for changes in parameters for the study as a whole. Conclusion. LDL lowering therapy over 1 year in PAD did not improve calf muscle perfusion, cellular metabolism, or exercise parameters. Statins are known to decrease risk of myocardial infarction, stroke, and death in PAD, but LDL lowering per se does not improve exercise calf muscle physiology or exercise performance.

Quantitative contrast‐enhanced myocardial perfusion magnetic resonance imaging: Simulation of bolus dispersion in constricted vessels

Quantification of myocardial blood flow (MBF) by means of T1-weighted first-pass magnetic resonance imaging (MRI) requires knowledge of the arterial input function (AIF), which is usually estimated from the left ventricle (LV). Dispersion of the contrast agent bolus may occur between the LV and the tissue of interest, which leads to systematic underestimation of the MBF. The aim of this study was to simulate the dispersion along a simplified coronary artery with different stenoses. To analyze the dispersion in vessels with typical dimensions of coronary arteries, simulations were performed using the computational fluid dynamics approach. Simulations were accomplished on straight vessels with integrated stenoses of different degrees of area reduction and length as well as two different shapes-an axial symmetric and an asymmetric. Two boundary conditions were used representing myocardial blood flow at rest and under hyperemic conditions. The results under steady boundary conditions show that the dispersion is more pronounced in resting condition than during hyperemia yielding an underestimation of the MBF around 15% in the resting state and around 8% under stress conditions. At the outlet of the vessel an axial symmetric stenosis results in increased dispersion whereas an asymmetric stenosis yields a reduction. Due to the more severe dispersion, resting MBF may be more underestimated in quantitative myocardial perfusion MRI studies compared with MBF under stress conditions. In consequence the myocardial perfusion reserve may be overestimated. The amount of systematic error depends in a complex way on the shape and degree of stenoses.

Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent

Cardiac magnetic resonance (MR) perfusion imaging during the first pass after intravenous administration of extracellular contrast agents is hampered by the spatial and temporal resolution achievable and by the artifacts seen in ultrafast MR imaging. Furthermore, time-consuming quantitative data analysis is often added. The use of molecular MR imaging with a target-specific contrast agent with perfusion-dependent binding to myocardium may enable prolonged visualization of perfusion defects and thus may help to overcome limitations of currently used first-pass extracellular MR imaging. EP-3600 is a new gadolinium-containing molecular contrast agent that binds reversibly to myocardial collagen. A significant but nonocclusive coronary artery stenosis was modeled in 7 domestic swine with an undersized MR-compatible balloon positioned in the left anterior descending artery as verified by x-ray angiography. Two animals died before contrast injection as a result of arrhythmias. In 5 swine, high-spatial-resolution gradient echo imaging (approximately 1 x 1 mm(2) in-plane resolution) was performed before and 5, 20, 40, and 60 minutes after intravenous administration of 12.3 micromol/kg EP-3600. Contrast was administered during stress induced by an infusion of 250 mumol x kg(-1) x min(-1) adenosine. Yb-DTPA was administered simultaneously for comparison of myocardium-to-plasma ratios. Images were assessed subjectively by 2 investigators, and signal-to-noise and contrast-to-noise ratios over time were calculated. Normal myocardium showed a significant signal-to-noise ratio increase during the entire examination time. In all animals (n=5), the perfusion defect in the left anterior descending artery territory could be visualized with a high contrast-to-noise ratio for at least 20 minutes after contrast injection. A significantly higher myocardium-to-plasma ratio was found for EP-3600 compared with the control agent Yb-DTPA (0.85+/-0.26 versus 0.22+/-0.08, respectively; P<0.01). EP-3600 is a new molecular MR imaging contrast agent that binds to the myocardium and enables prolonged, high-contrast, high-spatial-resolution visualization of myocardial perfusion defects.

Quantification of myocardial perfusion using free‐breathing MRI and prospective slice tracking

Quantification of myocardial perfusion using first-pass magnetic resonance imaging (MRI) is hampered by respiratory motion of the heart. Prospective slice tracking (PST) potentially overcomes this problem, and may provide an attractive alternative or supplement to current breath-hold techniques. This study demonstrates the feasibility of patient-adapted 3D PST on a 3.0 Tesla MR system. Eight patients underwent free-breathing studies of myocardial perfusion, simultaneously collecting data with and without PST. On average, PST reduced residual in-plane motion by a factor of 2, compared to the noncorrected images, resulting in a fourfold improvement of perfusion measurements. In addition, a comparison of perfusion measurements performed with and without PST showed that through-plane motion can contaminate measurements of myocardial perfusion. However, the quality of the navigator echoes on this field strength constituted a major source of error and needs further improvement to increase the accuracy and robustness of the method.

Reperfused Myocardial Infarction: Contrast-enhanced 64-Section CT in Comparison to MR Imaging

To prospectively compare 64-section multidetector computed tomography (CT) and cardiac magnetic resonance (MR) imaging for the early assessment of myocardial enhancement and infarct size after acute reperfused myocardial infarction (MI). The study was HIPAA compliant and was approved by the institutional review board. All participants gave written informed consent. Twenty-one patients (18 men; mean age, 60 years +/- 13 [standard deviation]) were examined with 64-section multidetector CT and cardiac MR imaging 5 days or fewer after a first reperfused MI. Multidetector CT was performed during the first pass of contrast material to assess myocardial perfusion and detect microvascular obstruction (no reflow). In 15 patients, a second scan was performed 7 minutes later to assess total infarct size by using delayed hyperenhancement. Early hypoenhancement and delayed hyperenhancement were compared between multidetector CT and cardiac MR imaging with Pearson correlation coefficient and Bland-Altman analysis. Early hypoenhancement was recognized on all multidetector CT and cardiac MR images. Delayed hyperenhancement was observed with cardiac MR imaging at all examinations and with multidetector CT at 11 of 15 examinations. While signal intensity differences between hypoperfused and normal myocardium were comparable for first-pass multidetector CT and cardiac MR imaging, cardiac MR imaging had a far better contrast-to-noise ratio (CNR) for delayed acquisitions than did CT (P < .001). Hypoenhanced areas (as a percentage of left ventricular mass) at first-pass multidetector CT (11% +/- 6) correlated well with those at first-pass cardiac MR imaging (7% +/- 4, R(2) = 0.72). Delayed-enhancement multidetector CT (13% +/- 9) correlated well with delayed-enhancement cardiac MR imaging (15% +/- 7, R(2) = 0.55). Quantification of delayed hypoenhancement (n = 12) had very good correlation between multidetector CT (4% +/- 4) and cardiac MR imaging (3% +/- 2) (R(2) = 0.85). Early and late hypoenhancement showed good CNR and correlated well between multidetector CT and cardiac MR imaging.

Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced maxgnetic resonance imaging

We report a case of apical hypertrophic cardiomyopathy (HCM) presenting with non-sustained ventricular tachycardia. Whole-heart magnetic resonance imaging (MRI) showed normal coronary arteries and confirmed the diagnosis of apical HCM. First-pass gadolinium delayed-enhanced MRI showed local delayed enhancement in the endomyocardium in the hypertrophic lesion. The presence of perfusion defect and delayed enhancement may be a marker of a high-risk patient with apical HCM.

Diagnostic value of late gadolinium-enhanced MRI and first-pass dynamic MRI for predicting functional recovery in patients after acute myocardial infarction

The aim of this study was to determine the comparative diagnostic values of late gadolinium-enhanced magnetic resonance imaging (MRI) and first-pass dynamic MRI for predicting functional recovery of regional myocardial contraction in patients early after acute myocardial infarction. First-pass and late-enhanced MRI were performed in 18 patients 5.5 +/- 2.5 days after the onset of myocardial infarction. Images analysis was performed using a 12-segment model. Regional systolic wall thickening (SWT) was measured on cine-MRI obtained 273 +/- 130 days later. Late-enhanced MRI revealed hyperenhancement in all patients, whereas hypoenhancement on first-pass MRI was observed in 67% (12/18) of the patients. The area under the receiver operating characteristics curve was 0.86 for late-enhanced MRI and 0.74 for first-pass MRI (P = 0.27). First-pass MRI was useful for predicting functional recovery of the segments that showed hyperenhancement of >50% of tissue on late-enhanced MRI. In these segments, preserved SWT was observed in 15 of 33 segments (45%) with first-pass hypoenhancement of < or =50% of tissue, but in only 2 of 22 segments (9%) with first-pass hypoenhancement of >50% of tissue. Whereas the diagnostic capability of first-pass MRI alone is limited, complementary use of first-pass MRI can enhance the diagnostic performance of late-enhanced MRI because hypoenhancement during first-pass imaging is more specific to nonviable myocardium.

4.26

4.26

Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside

This review paper presents, in the first part, the different classes of contrast media that are already used or are in development for cardiac magnetic resonance imaging. A classification of the different types of contrast media is proposed based on the distribution of the compounds in the body, their type of relaxivity and their potential affinity to particular molecules. In the second part, the different uses of the extracellular type of T1-enhancing contrast agent for myocardial imaging is covered from the detection of stable coronary artery disease to the detection and characterization of chronic infarction. A particular emphasis is placed on the clinical use of gadolinium-chelates, which are the universally used type of MRI contrast agent in the clinical routine. Both approaches, first-pass magnetic resonance imaging (FP-MRI) as well as delayed-enhanced magnetic resonance imaging (DE-MRI), are covered in the different situations of acute and chronic myocardial infarction.

Comparison Between Contrast Echocardiography and Magnetic Resonance Imaging to Predict Improvement of Myocardial Function After Primary Coronary Intervention

The relative merits of myocardial contrast echocardiography (MCE) and magnetic resonance imaging (MRI) to predict myocardial function improvement after percutaneous coronary intervention have not been evaluated until now. We studied 35 consecutive patients with acute myocardial infarction who underwent percutaneous coronary intervention using MCE and MRI and first-pass imaging for evaluation of myocardial perfusion. Delayed-enhanced MRI was included as another method to differentiate viable from infarcted tissue. MCE was performed by power modulation and intravenous Sonovue. A 16-segment model of the left ventricle was used to analyze all myocardial contrast echocardiograms and magnetic resonance images. At 60 days of follow-up, MCE showed improvement of function in 115 of 192 (60%) dysfunctional segments. The sensitivity, specificity, and accuracy for the prediction of functional improvement were comparable among MCE (87%, 90%, and 88%), first-pass MRI (87%, 60%, and 79%), and delayed-enhancement MRI (75%, 100%, and 82%, respectively, all p = NS). In conclusion, MCE and MRI allowed for prediction of myocardial function improvement after percutaneous coronary intervention. MCE had a comparable accuracy and, as a bedside technique, may be an alternative tool in the acute phase of acute myocardial infarction.

Realignment of myocardial first-pass MR perfusion images using an automatic detection of the heart-lung interface.

Magnetic resonance first-pass imaging of a bolus of contrast agent is well adapted to distinguish normal and hypoperfused areas of the myocardium. In most cases, the signal intensity-time curves in user defined regions of interest (ROI) are studied. As image acquisition is ECG-gated, the images are acquired at the same moment in the cardiac cycle, and the basic shape of the heart is similar from one view to the next. However, superficial respiratory motion can displace the heart in the short-axis plane. The aim of this study is to correct for the respiratory motion of the heart by performing an automatic realignment of the myocardial ROI based on a method tracking the movement of the lung-myocardium interface. Visual and quantitative analyses performed on 120 curves show a very good concordance between two automatic methods and the manual one.

Imaging of myocardial perfusion with magnetic resonance.

Coronary artery disease (CAD) is currently the leading cause of death in developed nations. Reflecting the complexity of cardiac function and morphology, noninvasive diagnosis of CAD represents a major challenge for medical imaging. Although coronary artery stenoses can be depicted with magnetic resonance (MR) and computed tomography (CT) techniques, its functional or hemodynamic impact frequently remains elusive. Therefore, there is growing interest in other, target organ-specific parameters such as myocardial function at stress and first-pass myocardial perfusion imaging to assess myocardial blood flow. This review explores the pathophysiologic background, recent technical developments, and current clinical status of first-pass MR imaging (MRI) of myocardial perfusion.

First-pass magnetic resonance imaging myocardial perfusion can determine microvascular dysfunction in acute myocardial infarction: Validation against angiographic thrombolysis in myocardial infarction frame count and myocardial blush score

First-pass magnetic resonance imaging myocardial perfusion can determine microvascular dysfunction in acute myocardial infarction: Validation against angiographic thrombolysis in myocardial infarction frame count and myocardial blush score